Michelle N. Meyer was a Research Fellow at the NCDG and is a J.D. candidate at Harvard Law School. She holds a Ph.D. in Ethics from the University of Virginia, where she taught in the Departments of Religious Studies and Philosophy, as well as in the Medical School. She received her A.B. summa cum laude and Phi Beta Kappa from Dartmouth College.
Her longstanding research interests include bioethics, especially genetics and reproductive technologies; feminist theory and ethics; and existentialism. She was a contributor to Ethical Issues in Human Stem Cell Research (1999), a report by the National Bioethics Advisory Commission, and to Conclusions of the 3rd Gene Therapy Policy Conference (1999), a report by the Recombinant Advisory Committee of the National Institutes of Health.
Meyer’s work at the Center focuses on the ethical, legal, and social implications of various uses of DNA in the criminal justice system, with particular attention to post-conviction DNA testing and law enforcement DNA databases. Most recently, she is the co-author, with Professor David Lazer, of "DNA and the Criminal Justice System: Consensus and Debate," in The Technology of Justice: DNA and the Criminal Justice System (MIT Press).